Cleo Diagnostics Ltd (ASX:COV)
Australia
· Delayed Price · Currency is AUD
0.530
+0.025 (4.95%)
Last updated: Mar 10, 2026, 1:51 PM AEST
Cleo Diagnostics Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 |
| Net Income | -4.03 | -4 | -3.76 | -1.73 |
| Depreciation & Amortization | 0.06 | 0.06 | 0.06 | 0.04 |
| Stock-Based Compensation | 0.44 | 0.44 | 1.5 | 0.78 |
| Other Operating Activities | 0.42 | - | -0.17 | 0 |
| Change in Accounts Receivable | 0.02 | 0.02 | -0.01 | -0.03 |
| Change in Accounts Payable | 0.56 | 0.56 | 0.02 | 0.37 |
| Change in Other Net Operating Assets | 0.02 | 0.02 | 0.33 | -0.12 |
| Operating Cash Flow | -2.51 | -2.9 | -2.03 | -0.68 |
| Capital Expenditures | -0.01 | -0.01 | -0 | -0.04 |
| Sale (Purchase) of Intangibles | - | - | - | -0.3 |
| Investing Cash Flow | -0.01 | -0.01 | -0 | -0.34 |
| Short-Term Debt Issued | - | - | - | 1.6 |
| Total Debt Issued | - | - | - | 1.6 |
| Short-Term Debt Repaid | - | - | - | -0.2 |
| Total Debt Repaid | - | - | - | -0.2 |
| Net Debt Issued (Repaid) | - | - | - | 1.4 |
| Issuance of Common Stock | 5.01 | - | 12 | - |
| Other Financing Activities | -0.37 | - | -0.83 | -0.18 |
| Financing Cash Flow | 4.64 | - | 11.17 | 1.22 |
| Net Cash Flow | 2.12 | -2.91 | 9.13 | 0.2 |
| Free Cash Flow | -2.52 | -2.91 | -2.03 | -0.72 |
| Free Cash Flow Margin | -98.35% | -344.57% | -964.47% | - |
| Free Cash Flow Per Share | -0.02 | -0.02 | -0.02 | -0.03 |
| Levered Free Cash Flow | -1.25 | -1.46 | -0.4 | - |
| Unlevered Free Cash Flow | -1.25 | -1.46 | -0.38 | - |
| Change in Working Capital | 0.6 | 0.6 | 0.34 | 0.22 |
Source: S&P Capital IQ. Standard template.
Financial Sources.